Business
University of Michigan study presentation at ANESTHESIOLOGY 2025 supports clinical and environmental benefits of End-tidal Control
CHICAGO, October 13, 2025--GE HealthCare (Nasdaq: GEHC) today announced the presentation of findings from the largest real-world evidence study to-date on End-tidal Control anesthesia delivery* software conducted at the University of Michigan. The results demonstrated the environmental and clinical benefits of End-tidal Control software and were presented at ANESTHESIOLOGY® 2025 taking place from October 10-14, in San Antonio, Texas.
About this update from Ge Healthcare Technologies Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":6570,"height":2242,"url":"https://media.zenfs.com/en/business-wire.com/c7f7b4ffcbf8fd1bae9ecbd651e4d109"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/R0dpDN8Uv6VH4KhL9vI5Gg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMyODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/c7f7b4ffcbf8fd1bae9ecbd651e4d109","width":960,"height":328},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/Rn2EdpzTb9e6Ft0l3tpGJg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/c7f7b4ffcbf8fd1bae9ecbd651e4d109","width":1200,"height":409}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"The retrospective analysis of nearly 15,000 general anesthesia cases of adults (18 years and older) at the University of Michigan demonstrated End-tidal Control’s association with reduced anesthetic agent usage and greenhouse gas emissions.","length":240,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"End-tidal Control is the first and only FDA-approved software that automatically adjusts to maintain end-tidal oxygen and end-tidal anesthetic agent concentrations set by the clinician, with more accuracy in reaching the clinician’s targets versus manual control.","length":263,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"The GE HealthCare booth (#1314) at ANESTHESIOLOGY 2025 showcases the company’s advancing perioperative care portfolio that supports clinical workflows and individualized patient care.","length":183,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":686,"olType":false},{"type":"text","content":"CHICAGO, October 13, 2025--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the presentation of findings from the largest real-world evidence study to-date on End-tidal Control anesthesia delivery* software conducted at the University of Michigan. The results demonstrated the environmental and clinical benefits of End-tidal Control software and were presented at ANESTHESIOLOGY® 2025 taking place from October 10-14, in San Antonio, Texas.","length":454,"tagName":"p"},{"type":"text","content":"End-tidal Control software supports the clinician in maintaining clinician-set targets for end-tidal an...